The Food and Drug Administration on Nov. 19 recommended removing from the market propoxyphene, a painkiller commonly sold as Darvon and Darvocet.
On the same day, physician users of the free, Web-based and advertiser supported electronic health records system of Practice Fusion received an alert from the San Francisco-based vendor.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access